HLNNYSE
Haleon plc
$9.09
ListedJul 25, 2022
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryUnited Kingdom
Employees24535
State-| CityWeybridge| AddressThe Heights| Phone44 1932 959 500
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
18.1
?
Div. Rate
$0.19
?
Div. Yield
2.13%
?
Payout Ratio
37.08%
?
Max Consec. Div. Years
3 years
?
Longest Consec. Div.
3 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.28
?
Div. Growth Rate
100.00%
?
Score
91

Dividend History

Historical dividend payments by ex-dividend date.

Apr 10, 2026
$ 0.1310
Apr 9, 2026
$ 0.1300
Aug 15, 2025
$ 0.0600
Apr 25, 2025
$ 0.1200
Aug 16, 2024
$ 0.0500
Mar 14, 2024
$ 0.1100
Aug 24, 2023
$ 0.0400
Mar 16, 2023
$ 0.0600

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!